Skip to main content
Caplight Logo









Natural MedTech

Natural MedTech

Private
MelbourneHealthcare & Life Scienceshttps://naturalmedtech.com

Last Round

Early Funding

May 31, 2024

Company Overview

Natural MedTech operates in Healthcare & Life Sciences and is based in Melbourne. Its latest recorded funding round was a Grant round in May 2022.

Natural MedTech is a biotechnology company that manufactures psychedelic medicines and active pharmaceutical ingredients using biosynthesis and precision fermentation.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Mental Health, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Natural MedTech Comparables

Compare Natural MedTech with similar companies based on industry and business-model similarity.

Natural MedTech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Psygen Industries Ltd.
81%
PsyLabs
81%
CB Therapeutics
80%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Natural MedTech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingMay 31, 2024
GrantMay 18, 2022
AcceleratorJan 15, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Natural MedTech Investors

Notable investors and investment history

Natural MedTech investors
InvestorRounds
Tabula Rasa VenturesAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 31, 2024

    Raised $4M in early funding.

  • May 18, 2022

    Received grant funding from CSIRO.

Book a demo to see all signals

For institutional investors. Book with your work email.

Natural MedTech Filings

Explore SEC and related filing metadata, where available.

Natural MedTech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Natural MedTech's valuation, stock price, and market status.

Is Natural MedTech a public or private company?

Natural MedTech is a private company.

What is the current stock price of Natural MedTech?

Natural MedTech is a private company, so its shares have no public market price. Caplight tracks Natural MedTech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Natural MedTech worth (valuation)?

Valuation information for Natural MedTech is not publicly available.

Can I buy Natural MedTech stock?

Natural MedTech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Natural MedTech's last funding round?

Natural MedTech's most recent funding round was Early Funding on May 31, 2024.

Who are the main investors in Natural MedTech?

Key investors in Natural MedTech include Tabula Rasa Ventures.

Will Natural MedTech IPO soon?

No public IPO plans have been announced for Natural MedTech.

How can I track Natural MedTech secondary market activity?

Caplight tracks bids, offers, and trades in Natural MedTech's shares on secondary markets.

Firmographic Details

HeadquartersMelbourne
Employee Range9
Year Founded2021
Last FundingMay 31, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?